SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-23-009385
Filing Date
2023-03-29
Accepted
2023-03-29 08:00:32
Documents
77
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1630042
2 ex23-1.htm EX-23.1 4364
3 ex31-1.htm EX-31.1 11434
4 ex31-2.htm EX-31.2 11007
5 ex31-3.htm EX-31.3 11423
6 ex32-1.htm EX-32.1 12788
  Complete submission text file 0001493152-23-009385.txt   6596620

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE cocp-20221231.xsd EX-101.SCH 43090
8 XBRL CALCULATION FILE cocp-20221231_cal.xml EX-101.CAL 59427
9 XBRL DEFINITION FILE cocp-20221231_def.xml EX-101.DEF 165272
10 XBRL LABEL FILE cocp-20221231_lab.xml EX-101.LAB 359144
11 XBRL PRESENTATION FILE cocp-20221231_pre.xml EX-101.PRE 285951
71 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1076670
Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38418 | Film No.: 23771806
SIC: 2834 Pharmaceutical Preparations